aluates Reports

$ 0.0

Automative

Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-18K11240

Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2022

BUY CHAPTERS

Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2025

Code: QYRE-Auto-18K11240

Report

March 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Olympus

LungCare

Broncus

Intuitive Surgica

Auris Health

AngioDynamics

Boston Scientific

Smith and Nephew

VISON Medical

Nanjing Micro-Tech

Minimally Invasive Treatment of Lung Cancer Market Size

The global market for Minimally Invasive Treatment of Lung Cancer was valued at US$ 3844 million in the year 2024 and is projected to reach a revised size of US$ 6880 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Minimally Invasive Treatment of Lung Cancer Market

The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer.

The Minimally Invasive Treatment of Lung Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Minimally Invasive Treatment of Lung Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Minimally Invasive Treatment of Lung Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Minimally Invasive Treatment of Lung Cancer Market Report

Report Metric	Details
Report Name	Minimally Invasive Treatment of Lung Cancer Market
Accounted market size in year	US$ 3844 million
Forecasted market size in 2031	US$ 6880 million
CAGR	8.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lung Tumor Ablation Lung Tumor Embolization
Segment by Application	Hospitals Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific, Smith and Nephew, VISON Medical, Nanjing MICRO-TECH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Minimally Invasive Treatment of Lung Cancer Market growing?

Ans: The Minimally Invasive Treatment of Lung Cancer Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Minimally Invasive Treatment of Lung Cancer Market size in 2031?

Ans: The Minimally Invasive Treatment of Lung Cancer Market size in 2031 will be US$ 6880 million.

Who are the main players in the Minimally Invasive Treatment of Lung Cancer Market report?

Ans: The main players in the Minimally Invasive Treatment of Lung Cancer Market are Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific, Smith and Nephew, VISON Medical, Nanjing MICRO-TECH

What are the Application segmentation covered in the Minimally Invasive Treatment of Lung Cancer Market report?

Ans: The Applications covered in the Minimally Invasive Treatment of Lung Cancer Market report are Hospitals, Ambulatory Surgical Centers

What are the Type segmentation covered in the Minimally Invasive Treatment of Lung Cancer Market report?

Ans: The Types covered in the Minimally Invasive Treatment of Lung Cancer Market report are Lung Tumor Ablation, Lung Tumor Embolization

Recommended Reports

Lung Cancer Markets

Cancer Therapy Devices

Minimally Invasive Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Lung Tumor Ablation

1.2.3 Lung Tumor Embolization

1.3 Market by Application

1.3.1 Global Minimally Invasive Treatment of Lung Cancer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Minimally Invasive Treatment of Lung Cancer Market Perspective (2020-2031)

2.2 Global Minimally Invasive Treatment of Lung Cancer Growth Trends by Region

2.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Minimally Invasive Treatment of Lung Cancer Historic Market Size by Region (2020-2025)

2.2.3 Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2026-2031)

2.3 Minimally Invasive Treatment of Lung Cancer Market Dynamics

2.3.1 Minimally Invasive Treatment of Lung Cancer Industry Trends

2.3.2 Minimally Invasive Treatment of Lung Cancer Market Drivers

2.3.3 Minimally Invasive Treatment of Lung Cancer Market Challenges

2.3.4 Minimally Invasive Treatment of Lung Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue

3.1.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue (2020-2025)

3.1.2 Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Players (2020-2025)

3.2 Global Minimally Invasive Treatment of Lung Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Minimally Invasive Treatment of Lung Cancer Revenue

3.4 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio

3.4.1 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Minimally Invasive Treatment of Lung Cancer Revenue in 2024

3.5 Global Key Players of Minimally Invasive Treatment of Lung Cancer Head office and Area Served

3.6 Global Key Players of Minimally Invasive Treatment of Lung Cancer, Product and Application

3.7 Global Key Players of Minimally Invasive Treatment of Lung Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Type

4.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Type (2020-2025)

4.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2026-2031)

5 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Application

5.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Application (2020-2025)

5.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Minimally Invasive Treatment of Lung Cancer Market Size (2020-2031)

6.2 North America Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025)

6.4 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size (2020-2031)

7.2 Europe Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025)

7.4 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size (2020-2031)

8.2 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2020-2025)

8.4 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Minimally Invasive Treatment of Lung Cancer Market Size (2020-2031)

9.2 Latin America Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025)

9.4 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size (2020-2031)

10.2 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025)

10.4 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic

11.1.1 Medtronic Company Details

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Introduction

11.1.4 Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.1.5 Medtronic Recent Development

11.2 Olympus

11.2.1 Olympus Company Details

11.2.2 Olympus Business Overview

11.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Introduction

11.2.4 Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.2.5 Olympus Recent Development

11.3 LungCare

11.3.1 LungCare Company Details

11.3.2 LungCare Business Overview

11.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Introduction

11.3.4 LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.3.5 LungCare Recent Development

11.4 Broncus

11.4.1 Broncus Company Details

11.4.2 Broncus Business Overview

11.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Introduction

11.4.4 Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.4.5 Broncus Recent Development

11.5 Intuitive Surgica

11.5.1 Intuitive Surgica Company Details

11.5.2 Intuitive Surgica Business Overview

11.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Introduction

11.5.4 Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.5.5 Intuitive Surgica Recent Development

11.6 Auris Health

11.6.1 Auris Health Company Details

11.6.2 Auris Health Business Overview

11.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Introduction

11.6.4 Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.6.5 Auris Health Recent Development

11.7 Angiodynamics

11.7.1 Angiodynamics Company Details

11.7.2 Angiodynamics Business Overview

11.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Introduction

11.7.4 Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.7.5 Angiodynamics Recent Development

11.8 Boston Scientific

11.8.1 Boston Scientific Company Details

11.8.2 Boston Scientific Business Overview

11.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Introduction

11.8.4 Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.8.5 Boston Scientific Recent Development

11.9 Smith and Nephew

11.9.1 Smith and Nephew Company Details

11.9.2 Smith and Nephew Business Overview

11.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Introduction

11.9.4 Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.9.5 Smith and Nephew Recent Development

11.10 VISON Medical

11.10.1 VISON Medical Company Details

11.10.2 VISON Medical Business Overview

11.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Introduction

11.10.4 VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.10.5 VISON Medical Recent Development

11.11 Nanjing MICRO-TECH

11.11.1 Nanjing MICRO-TECH Company Details

11.11.2 Nanjing MICRO-TECH Business Overview

11.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Introduction

11.11.4 Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

11.11.5 Nanjing MICRO-TECH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Olympus

LungCare

Broncus

Intuitive Surgica

Auris Health

AngioDynamics

Boston Scientific

Smith and Nephew

VISON Medical

Nanjing Micro-Tech

List of Tables

Table 1. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Lung Tumor Ablation

Table 3. Key Players of Lung Tumor Embolization

Table 4. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2020-2025)

Table 8. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2026-2031)

Table 10. Minimally Invasive Treatment of Lung Cancer Market Trends

Table 11. Minimally Invasive Treatment of Lung Cancer Market Drivers

Table 12. Minimally Invasive Treatment of Lung Cancer Market Challenges

Table 13. Minimally Invasive Treatment of Lung Cancer Market Restraints

Table 14. Global Minimally Invasive Treatment of Lung Cancer Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players (2020-2025)

Table 16. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2024)

Table 17. Ranking of Global Top Minimally Invasive Treatment of Lung Cancer Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Minimally Invasive Treatment of Lung Cancer, Headquarters and Area Served

Table 20. Global Key Players of Minimally Invasive Treatment of Lung Cancer, Product and Application

Table 21. Global Key Players of Minimally Invasive Treatment of Lung Cancer, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2020-2025)

Table 25. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2026-2031)

Table 27. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2020-2025)

Table 29. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2026-2031)

Table 31. North America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 46. Medtronic Company Details

Table 47. Medtronic Business Overview

Table 48. Medtronic Minimally Invasive Treatment of Lung Cancer Product

Table 49. Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 50. Medtronic Recent Development

Table 51. Olympus Company Details

Table 52. Olympus Business Overview

Table 53. Olympus Minimally Invasive Treatment of Lung Cancer Product

Table 54. Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 55. Olympus Recent Development

Table 56. LungCare Company Details

Table 57. LungCare Business Overview

Table 58. LungCare Minimally Invasive Treatment of Lung Cancer Product

Table 59. LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 60. LungCare Recent Development

Table 61. Broncus Company Details

Table 62. Broncus Business Overview

Table 63. Broncus Minimally Invasive Treatment of Lung Cancer Product

Table 64. Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 65. Broncus Recent Development

Table 66. Intuitive Surgica Company Details

Table 67. Intuitive Surgica Business Overview

Table 68. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product

Table 69. Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 70. Intuitive Surgica Recent Development

Table 71. Auris Health Company Details

Table 72. Auris Health Business Overview

Table 73. Auris Health Minimally Invasive Treatment of Lung Cancer Product

Table 74. Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 75. Auris Health Recent Development

Table 76. Angiodynamics Company Details

Table 77. Angiodynamics Business Overview

Table 78. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product

Table 79. Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 80. Angiodynamics Recent Development

Table 81. Boston Scientific Company Details

Table 82. Boston Scientific Business Overview

Table 83. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product

Table 84. Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 85. Boston Scientific Recent Development

Table 86. Smith and Nephew Company Details

Table 87. Smith and Nephew Business Overview

Table 88. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product

Table 89. Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 90. Smith and Nephew Recent Development

Table 91. VISON Medical Company Details

Table 92. VISON Medical Business Overview

Table 93. VISON Medical Minimally Invasive Treatment of Lung Cancer Product

Table 94. VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 95. VISON Medical Recent Development

Table 96. Nanjing MICRO-TECH Company Details

Table 97. Nanjing MICRO-TECH Business Overview

Table 98. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product

Table 99. Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2020-2025) & (US$ Million)

Table 100. Nanjing MICRO-TECH Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Minimally Invasive Treatment of Lung Cancer Picture

Figure 2. Global Minimally Invasive Treatment of Lung Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Minimally Invasive Treatment of Lung Cancer Market Share by Type: 2024 VS 2031

Figure 4. Lung Tumor Ablation Features

Figure 5. Lung Tumor Embolization Features

Figure 6. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Minimally Invasive Treatment of Lung Cancer Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Ambulatory Surgical Centers Case Studies

Figure 10. Minimally Invasive Treatment of Lung Cancer Report Years Considered

Figure 11. Global Minimally Invasive Treatment of Lung Cancer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Minimally Invasive Treatment of Lung Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region: 2024 VS 2031

Figure 14. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players in 2024

Figure 15. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2024

Figure 17. North America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2020-2031)

Figure 19. United States Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Country (2020-2031)

Figure 23. Germany Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Share by Region (2020-2031)

Figure 31. China Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2020-2031)

Figure 39. Mexico Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Country (2020-2031)

Figure 43. Turkey Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Medtronic Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 47. Olympus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 48. LungCare Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 49. Broncus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 50. Intuitive Surgica Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 51. Auris Health Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 52. Angiodynamics Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 53. Boston Scientific Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 54. Smith and Nephew Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 55. VISON Medical Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 56. Nanjing MICRO-TECH Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Interventional Pulmonology Device Market Research Report 2025

Robotic Lung Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Minimal Invasive Surgery Devices Market Research Report 2024

Global Minimally Invasive Surgical Devices Market Research Report 2024

Global Minimally Invasive Surgical MIS Devices Market Insights Forecast to 2030

Minimally Invasive Prostate Cancer Surgery Market

Global Lung Biopsy Systems Market Research Report 2024

Global Minimally Invasive Tumor Treatment Technology Market Research Report 2024

Global Lung Tumor Ablation Market Research Report 2025

Global Metastatic Lung Adenocarcinoma Treatment Market Research Report 2024

Lung Cancer Surgery Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Minimally Invasive Thoracic Surgery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Small Cell Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Laparoscopic Tumor Ablation Market Research Report 2025

Global Oncology Ablation Market Insights Forecast to 2030

Global Minimally Invasive Surgery Devices Market Research Report 2025

Global Lung Cancer Diagnostic And Screening Market Research Report 2024

Minimally Invasive Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Interventional Tumor Ablation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions